Compile Data Set for Download or QSAR

Found 35 hits Enz. Inhib. hit(s) with all data for entry = 50003170   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Sodium/glucose cotransporter 2 (Homo sapiens (Human))	BDBM50467845 (CHEMBL4288518) Show SMILES Cc1ccc(Cc2cc([C@@H]3S[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)cc2C)cc1 |r| Show InChI InChI=1S/C21H26O5S/c1-11-3-5-13(6-4-11)8-14-9-15(16(23)7-12(14)2)21-20(26)19(25)18(24)17(10-22)27-21/h3-7,9,17-26H,8,10H2,1-2H3/t17-,18-,19+,20-,21+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 1 hr by mi...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 2 (Homo sapiens (Human))	BDBM50467841 (CHEMBL4284073) Show SMILES CCc1ccc(Cc2cc([C@@H]3S[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)cc2C)cc1 |r| Show InChI InChI=1S/C22H28O5S/c1-3-13-4-6-14(7-5-13)9-15-10-16(17(24)8-12(15)2)22-21(27)20(26)19(25)18(11-23)28-22/h4-8,10,18-27H,3,9,11H2,1-2H3/t18-,19-,20+,21-,22+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	2	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 1 hr by mi...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 2 (Homo sapiens (Human))	BDBM50315418 ((1S)-1,5-Anhydro-1-[3-(4-ethoxybenzyl)-4-methylphe...) Show SMILES CCOc1ccc(Cc2cc(ccc2C)[C@@H]2S[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1 |r| Show InChI InChI=1S/C22H28O5S/c1-3-27-17-8-5-14(6-9-17)10-16-11-15(7-4-13(16)2)22-21(26)20(25)19(24)18(12-23)28-22/h4-9,11,18-26H,3,10,12H2,1-2H3/t18-,19-,20+,21-,22+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	2.30	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 1 hr by mi...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 2 (Homo sapiens (Human))	BDBM50467849 (CHEMBL4280615) Show SMILES CC(C)Oc1ccc(Cc2cc([C@@H]3S[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)cc2C)cc1 |r| Show InChI InChI=1S/C23H30O6S/c1-12(2)29-16-6-4-14(5-7-16)9-15-10-17(18(25)8-13(15)3)23-22(28)21(27)20(26)19(11-24)30-23/h4-8,10,12,19-28H,9,11H2,1-3H3/t19-,20-,21+,22-,23+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 1 hr by mi...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 2 (Homo sapiens (Human))	BDBM50467850 (CHEMBL4290854) Show SMILES CCOc1ccc(Cc2cc([C@@H]3S[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)cc2C)cc1 |r| Show InChI InChI=1S/C22H28O6S/c1-3-28-15-6-4-13(5-7-15)9-14-10-16(17(24)8-12(14)2)22-21(27)20(26)19(25)18(11-23)29-22/h4-8,10,18-27H,3,9,11H2,1-2H3/t18-,19-,20+,21-,22+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 1 hr by mi...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 2 (Homo sapiens (Human))	BDBM50467840 (CHEMBL4286329) Show SMILES Cc1cc(O)c(cc1Cc1ccc(CCNC(=O)NC(C)(C)CO)cc1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O |r| Show InChI InChI=1S/C27H38N2O8/c1-15-10-20(32)19(25-24(35)23(34)22(33)21(13-30)37-25)12-18(15)11-17-6-4-16(5-7-17)8-9-28-26(36)29-27(2,3)14-31/h4-7,10,12,21-25,30-35H,8-9,11,13-14H2,1-3H3,(H2,28,29,36)/t21-,22-,23+,24-,25+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	4	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 1 hr by mi...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 2 (Homo sapiens (Human))	BDBM50467843 (CHEMBL4290434) Show SMILES Cc1cc(O)c(cc1Cc1ccc(\C=C\CC(=O)NC(C)(C)C(N)=O)cc1)[C@@H]1S[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O |r| Show InChI InChI=1S/C28H36N2O7S/c1-15-11-20(32)19(26-25(36)24(35)23(34)21(14-31)38-26)13-18(15)12-17-9-7-16(8-10-17)5-4-6-22(33)30-28(2,3)27(29)37/h4-5,7-11,13,21,23-26,31-32,34-36H,6,12,14H2,1-3H3,(H2,29,37)(H,30,33)/b5-4+/t21-,23-,24+,25-,26+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	4	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 1 hr by mi...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 2 (Homo sapiens (Human))	BDBM50467854 (CHEMBL4291937) Show SMILES Cc1cc(O)c(cc1Cc1ccc(\C=C\CC(=O)NC(C)(CO)CO)cc1)[C@@H]1S[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O |r| Show InChI InChI=1S/C28H37NO8S/c1-16-10-21(33)20(27-26(37)25(36)24(35)22(13-30)38-27)12-19(16)11-18-8-6-17(7-9-18)4-3-5-23(34)29-28(2,14-31)15-32/h3-4,6-10,12,22,24-27,30-33,35-37H,5,11,13-15H2,1-2H3,(H,29,34)/b4-3+/t22-,24-,25+,26-,27+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 1 hr by mi...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 2 (Homo sapiens (Human))	BDBM50467851 (CHEMBL4290161) Show SMILES CN1CCN(CC1)C(=O)NCCCc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)cc2C)cc1 |r| Show InChI InChI=1S/C29H41N3O7/c1-18-14-23(34)22(28-27(37)26(36)25(35)24(17-33)39-28)16-21(18)15-20-7-5-19(6-8-20)4-3-9-30-29(38)32-12-10-31(2)11-13-32/h5-8,14,16,24-28,33-37H,3-4,9-13,15,17H2,1-2H3,(H,30,38)/t24-,25-,26+,27-,28+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 1 hr by mi...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 2 (Homo sapiens (Human))	BDBM50467842 (CHEMBL4289746) Show SMILES Cc1cc(O)c(cc1Cc1ccc(CCCNC(=O)NC(C)(C)CO)cc1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O |r| Show InChI InChI=1S/C28H40N2O8/c1-16-11-21(33)20(26-25(36)24(35)23(34)22(14-31)38-26)13-19(16)12-18-8-6-17(7-9-18)5-4-10-29-27(37)30-28(2,3)15-32/h6-9,11,13,22-26,31-36H,4-5,10,12,14-15H2,1-3H3,(H2,29,30,37)/t22-,23-,24+,25-,26+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	5	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 1 hr by mi...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 2 (Homo sapiens (Human))	BDBM50467848 (CHEMBL4281880) Show SMILES Cc1cc(O)c(cc1Cc1ccc(CCCNC(=O)NC(CO)(CO)CO)cc1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O |r| Show InChI InChI=1S/C28H40N2O10/c1-16-9-21(35)20(26-25(38)24(37)23(36)22(12-31)40-26)11-19(16)10-18-6-4-17(5-7-18)3-2-8-29-27(39)30-28(13-32,14-33)15-34/h4-7,9,11,22-26,31-38H,2-3,8,10,12-15H2,1H3,(H2,29,30,39)/t22-,23-,24+,25-,26+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	7	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 1 hr by mi...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 2 (Homo sapiens (Human))	BDBM50467855 (CHEMBL4279495) Show SMILES Cc1cc(O)c(cc1Cc1ccc(\C=C\CC(=O)NC(C)(C)C(N)=O)cc1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O |r| Show InChI InChI=1S/C28H36N2O8/c1-15-11-20(32)19(26-25(36)24(35)23(34)21(14-31)38-26)13-18(15)12-17-9-7-16(8-10-17)5-4-6-22(33)30-28(2,3)27(29)37/h4-5,7-11,13,21,23-26,31-32,34-36H,6,12,14H2,1-3H3,(H2,29,37)(H,30,33)/b5-4+/t21-,23-,24+,25-,26+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	7	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 1 hr by mi...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 2 (Homo sapiens (Human))	BDBM50467847 (CHEMBL4287309) Show SMILES Cc1cc(O)c(cc1Cc1ccc(CCNC(=O)NC(CO)(CO)CO)cc1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O |r| Show InChI InChI=1S/C27H38N2O10/c1-15-8-20(34)19(25-24(37)23(36)22(35)21(11-30)39-25)10-18(15)9-17-4-2-16(3-5-17)6-7-28-26(38)29-27(12-31,13-32)14-33/h2-5,8,10,21-25,30-37H,6-7,9,11-14H2,1H3,(H2,28,29,38)/t21-,22-,23+,24-,25+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	7	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 1 hr by mi...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 2 (Homo sapiens (Human))	BDBM50467846 (CHEMBL4282565) Show SMILES Cc1cc(O)c(cc1Cc1ccc(\C=C\CC(=O)NC(CO)(CO)CO)cc1)[C@@H]1S[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O |r| Show InChI InChI=1S/C28H37NO9S/c1-16-9-21(34)20(27-26(38)25(37)24(36)22(12-30)39-27)11-19(16)10-18-7-5-17(6-8-18)3-2-4-23(35)29-28(13-31,14-32)15-33/h2-3,5-9,11,22,24-27,30-34,36-38H,4,10,12-15H2,1H3,(H,29,35)/b3-2+/t22-,24-,25+,26-,27+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	9	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 1 hr by mi...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 2 (Homo sapiens (Human))	BDBM50315435 ((1S)-1,5-Anhydro-1-[5-(4-ethoxybenzyl)-2-hydroxyph...) Show SMILES CCOc1ccc(Cc2ccc(O)c(c2)[C@@H]2S[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1 |r| Show InChI InChI=1S/C21H26O6S/c1-2-27-14-6-3-12(4-7-14)9-13-5-8-16(23)15(10-13)21-20(26)19(25)18(24)17(11-22)28-21/h3-8,10,17-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	17	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 1 hr by mi...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM50467854 (CHEMBL4291937) Show SMILES Cc1cc(O)c(cc1Cc1ccc(\C=C\CC(=O)NC(C)(CO)CO)cc1)[C@@H]1S[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O |r| Show InChI InChI=1S/C28H37NO8S/c1-16-10-21(33)20(27-26(37)25(36)24(35)22(13-30)38-27)12-19(16)11-18-8-6-17(7-9-18)4-3-5-23(34)29-28(2,14-31)15-32/h3-4,6-10,12,22,24-27,30-33,35-37H,5,11,13-15H2,1-2H3,(H,29,34)/b4-3+/t22-,24-,25+,26-,27+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	22	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 30 mins by...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM50467845 (CHEMBL4288518) Show SMILES Cc1ccc(Cc2cc([C@@H]3S[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)cc2C)cc1 |r| Show InChI InChI=1S/C21H26O5S/c1-11-3-5-13(6-4-11)8-14-9-15(16(23)7-12(14)2)21-20(26)19(25)18(24)17(10-22)27-21/h3-7,9,17-26H,8,10H2,1-2H3/t17-,18-,19+,20-,21+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	25	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 30 mins by...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM50467847 (CHEMBL4287309) Show SMILES Cc1cc(O)c(cc1Cc1ccc(CCNC(=O)NC(CO)(CO)CO)cc1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O |r| Show InChI InChI=1S/C27H38N2O10/c1-15-8-20(34)19(25-24(37)23(36)22(35)21(11-30)39-25)10-18(15)9-17-4-2-16(3-5-17)6-7-28-26(38)29-27(12-31,13-32)14-33/h2-5,8,10,21-25,30-37H,6-7,9,11-14H2,1H3,(H2,28,29,38)/t21-,22-,23+,24-,25+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	28	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 30 mins by...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM50467841 (CHEMBL4284073) Show SMILES CCc1ccc(Cc2cc([C@@H]3S[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)cc2C)cc1 |r| Show InChI InChI=1S/C22H28O5S/c1-3-13-4-6-14(7-5-13)9-15-10-16(17(24)8-12(15)2)22-21(27)20(26)19(25)18(11-23)28-22/h4-8,10,18-27H,3,9,11H2,1-2H3/t18-,19-,20+,21-,22+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	32	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 30 mins by...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM50467853 (CHEMBL4282961) Show SMILES Cc1cc(O)c(cc1Cc1ccc(\C=C\CC(=O)NC(C)(CO)CO)cc1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O |r| Show InChI InChI=1S/C28H37NO9/c1-16-10-21(33)20(27-26(37)25(36)24(35)22(13-30)38-27)12-19(16)11-18-8-6-17(7-9-18)4-3-5-23(34)29-28(2,14-31)15-32/h3-4,6-10,12,22,24-27,30-33,35-37H,5,11,13-15H2,1-2H3,(H,29,34)/b4-3+/t22-,24-,25+,26-,27+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	32	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 30 mins by...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM50467852 (CHEMBL4293555) Show SMILES Cc1cc(O)c(cc1Cc1ccc(\C=C\CC(=O)NC(CO)(CO)CO)cc1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O |r| Show InChI InChI=1S/C28H37NO10/c1-16-9-21(34)20(27-26(38)25(37)24(36)22(12-30)39-27)11-19(16)10-18-7-5-17(6-8-18)3-2-4-23(35)29-28(13-31,14-32)15-33/h2-3,5-9,11,22,24-27,30-34,36-38H,4,10,12-15H2,1H3,(H,29,35)/b3-2+/t22-,24-,25+,26-,27+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	35	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 30 mins by...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM50467846 (CHEMBL4282565) Show SMILES Cc1cc(O)c(cc1Cc1ccc(\C=C\CC(=O)NC(CO)(CO)CO)cc1)[C@@H]1S[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O |r| Show InChI InChI=1S/C28H37NO9S/c1-16-9-21(34)20(27-26(38)25(37)24(36)22(12-30)39-27)11-19(16)10-18-7-5-17(6-8-18)3-2-4-23(35)29-28(13-31,14-32)15-33/h2-3,5-9,11,22,24-27,30-34,36-38H,4,10,12-15H2,1H3,(H,29,35)/b3-2+/t22-,24-,25+,26-,27+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	35	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 30 mins by...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM50467843 (CHEMBL4290434) Show SMILES Cc1cc(O)c(cc1Cc1ccc(\C=C\CC(=O)NC(C)(C)C(N)=O)cc1)[C@@H]1S[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O |r| Show InChI InChI=1S/C28H36N2O7S/c1-15-11-20(32)19(26-25(36)24(35)23(34)21(14-31)38-26)13-18(15)12-17-9-7-16(8-10-17)5-4-6-22(33)30-28(2,3)27(29)37/h4-5,7-11,13,21,23-26,31-32,34-36H,6,12,14H2,1-3H3,(H2,29,37)(H,30,33)/b5-4+/t21-,23-,24+,25-,26+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	47	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 30 mins by...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM50467840 (CHEMBL4286329) Show SMILES Cc1cc(O)c(cc1Cc1ccc(CCNC(=O)NC(C)(C)CO)cc1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O |r| Show InChI InChI=1S/C27H38N2O8/c1-15-10-20(32)19(25-24(35)23(34)22(33)21(13-30)37-25)12-18(15)11-17-6-4-16(5-7-17)8-9-28-26(36)29-27(2,3)14-31/h4-7,10,12,21-25,30-35H,8-9,11,13-14H2,1-3H3,(H2,28,29,36)/t21-,22-,23+,24-,25+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	51	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 30 mins by...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM50467855 (CHEMBL4279495) Show SMILES Cc1cc(O)c(cc1Cc1ccc(\C=C\CC(=O)NC(C)(C)C(N)=O)cc1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O |r| Show InChI InChI=1S/C28H36N2O8/c1-15-11-20(32)19(26-25(36)24(35)23(34)21(14-31)38-26)13-18(15)12-17-9-7-16(8-10-17)5-4-6-22(33)30-28(2,3)27(29)37/h4-5,7-11,13,21,23-26,31-32,34-36H,6,12,14H2,1-3H3,(H2,29,37)(H,30,33)/b5-4+/t21-,23-,24+,25-,26+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	51	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 30 mins by...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM50467842 (CHEMBL4289746) Show SMILES Cc1cc(O)c(cc1Cc1ccc(CCCNC(=O)NC(C)(C)CO)cc1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O |r| Show InChI InChI=1S/C28H40N2O8/c1-16-11-21(33)20(26-25(36)24(35)23(34)22(14-31)38-26)13-19(16)12-18-8-6-17(7-9-18)5-4-10-29-27(37)30-28(2,3)15-32/h6-9,11,13,22-26,31-36H,4-5,10,12,14-15H2,1-3H3,(H2,29,30,37)/t22-,23-,24+,25-,26+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	65	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 30 mins by...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM50467844 (CHEMBL4280221) Show SMILES COc1ccc(Cc2cc([C@@H]3S[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)cc2C)cc1 |r| Show InChI InChI=1S/C21H26O6S/c1-11-7-16(23)15(21-20(26)19(25)18(24)17(10-22)28-21)9-13(11)8-12-3-5-14(27-2)6-4-12/h3-7,9,17-26H,8,10H2,1-2H3/t17-,18-,19+,20-,21+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	65	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 30 mins by...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 2 (Homo sapiens (Human))	BDBM50315422 ((1S)-1,5-Anhydro-1-[3-(4-ethoxybenzyl)phenyl]-1-th...) Show SMILES CCOc1ccc(Cc2cccc(c2)[C@@H]2S[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1 |r| Show InChI InChI=1S/C21H26O5S/c1-2-26-16-8-6-13(7-9-16)10-14-4-3-5-15(11-14)21-20(25)19(24)18(23)17(12-22)27-21/h3-9,11,17-25H,2,10,12H2,1H3/t17-,18-,19+,20-,21+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	74	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT2 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 1 hr by mi...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM50467850 (CHEMBL4290854) Show SMILES CCOc1ccc(Cc2cc([C@@H]3S[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)cc2C)cc1 |r| Show InChI InChI=1S/C22H28O6S/c1-3-28-15-6-4-13(5-7-15)9-14-10-16(17(24)8-12(14)2)22-21(27)20(26)19(25)18(11-23)29-22/h4-8,10,18-27H,3,9,11H2,1-2H3/t18-,19-,20+,21-,22+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	162	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 30 mins by...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM50467848 (CHEMBL4281880) Show SMILES Cc1cc(O)c(cc1Cc1ccc(CCCNC(=O)NC(CO)(CO)CO)cc1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O |r| Show InChI InChI=1S/C28H40N2O10/c1-16-9-21(35)20(26-25(38)24(37)23(36)22(12-31)40-26)11-19(16)10-18-6-4-17(5-7-18)3-2-8-29-27(39)30-28(13-32,14-33)15-34/h4-7,9,11,22-26,31-38H,2-3,8,10,12-15H2,1H3,(H2,29,30,39)/t22-,23-,24+,25-,26+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	175	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 30 mins by...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM50467849 (CHEMBL4280615) Show SMILES CC(C)Oc1ccc(Cc2cc([C@@H]3S[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)cc2C)cc1 |r| Show InChI InChI=1S/C23H30O6S/c1-12(2)29-16-6-4-14(5-7-16)9-15-10-17(18(25)8-13(15)3)23-22(28)21(27)20(26)19(11-24)30-23/h4-8,10,12,19-28H,9,11H2,1-3H3/t19-,20-,21+,22-,23+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	414	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 30 mins by...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM50315418 ((1S)-1,5-Anhydro-1-[3-(4-ethoxybenzyl)-4-methylphe...) Show SMILES CCOc1ccc(Cc2cc(ccc2C)[C@@H]2S[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1 |r| Show InChI InChI=1S/C22H28O5S/c1-3-27-17-8-5-14(6-9-17)10-16-11-15(7-4-13(16)2)22-21(26)20(25)19(24)18(12-23)28-22/h4-9,11,18-26H,3,10,12H2,1-2H3/t18-,19-,20+,21-,22+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	671	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 30 mins by...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM50467851 (CHEMBL4290161) Show SMILES CN1CCN(CC1)C(=O)NCCCc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)cc2C)cc1 |r| Show InChI InChI=1S/C29H41N3O7/c1-18-14-23(34)22(28-27(37)26(36)25(35)24(17-33)39-28)16-21(18)15-20-7-5-19(6-8-20)4-3-9-30-29(38)32-12-10-31(2)11-13-32/h5-8,14,16,24-28,33-37H,3-4,9-13,15,17H2,1-2H3,(H,30,38)/t24-,25-,26+,27-,28+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	764	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 30 mins by...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM50315435 ((1S)-1,5-Anhydro-1-[5-(4-ethoxybenzyl)-2-hydroxyph...) Show SMILES CCOc1ccc(Cc2ccc(O)c(c2)[C@@H]2S[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1 |r| Show InChI InChI=1S/C21H26O6S/c1-2-27-14-6-3-12(4-7-14)9-13-5-8-16(23)15(10-13)21-20(26)19(25)18(24)17(11-22)28-21/h3-8,10,17-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	4.04E+3	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 30 mins by...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM50315422 ((1S)-1,5-Anhydro-1-[3-(4-ethoxybenzyl)phenyl]-1-th...) Show SMILES CCOc1ccc(Cc2cccc(c2)[C@@H]2S[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1 |r| Show InChI InChI=1S/C21H26O5S/c1-2-26-16-8-6-13(7-9-16)10-14-4-3-5-15(11-14)21-20(25)19(24)18(23)17(12-22)27-21/h3-9,11,17-25H,2,10,12H2,1H3/t17-,18-,19+,20-,21+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	2.61E+4	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd. Curated by ChEMBL					Assay Description Inhibition of human SGLT1 expressed in CHOK1 cells assessed as reduction in Na-dependent [14C]-methyl-alpha-D-glucopyranoside uptake after 30 mins by...				Bioorg Med Chem Lett 28: 3534-3539 (2018) Article DOI: 10.1016/j.bmcl.2018.09.035 BindingDB Entry DOI: 10.7270/Q2V40XWK
					More data for this Ligand-Target Pair